Category Archives: Johnson & Johnson

J&J Agrees to $2.2 Billion in Risperdal Whistleblower Case

In what is being described as one of the largest whistleblower payouts in the history of the United States, Johnson & Johnson agreed to pay $2.2 billion over the way in which the antipsychotic medication, Risperdal, was marketed, among other issues.

Read More

Johnson & Johnson Facing Two Governmental Probes Concerning Medical Devices

In separate disclosures, health care products giant, Johnson & Johnson, stated that government investigations are underway concerning two of its medical device products. Both its hip devices and its surgical mesh are involved in government probes, Bloomberg Businessweek, reports. Hip …

Read More